Malignant Urethral Neoplasm — Trials

Malignant Urethral Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00014144	S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract	completed	Phase 2	31	SWOG Cancer Research NetworkNETWORK	1	Oct 8, 2012	clinicaltrials
NCT00006026	Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract	completed	Phase 2	21	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	7	Sep 24, 2012	clinicaltrials